These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34285345)

  • 21. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative splicing of DNA damage response genes and gastrointestinal cancers.
    Rahmutulla B; Matsushita K; Nomura F
    World J Gastroenterol; 2014 Dec; 20(46):17305-13. PubMed ID: 25516641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
    Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
    Piekielko-Witkowska A; Wiszomirska H; Wojcicka A; Poplawski P; Boguslawska J; Tanski Z; Nauman A
    PLoS One; 2010 Oct; 5(10):e13690. PubMed ID: 21082031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of recurrent regulated alternative splicing events across human solid tumors.
    Danan-Gotthold M; Golan-Gerstl R; Eisenberg E; Meir K; Karni R; Levanon EY
    Nucleic Acids Res; 2015 May; 43(10):5130-44. PubMed ID: 25908786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic analysis of RNA alternative splicing in cancers.
    Xing Y
    Front Biosci; 2007 May; 12():4034-41. PubMed ID: 17485356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
    Vadlamudi Y; Dey DK; Kang SC
    Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
    Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
    Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.
    Chen K; Xiao H; Zeng J; Yu G; Zhou H; Huang C; Yao W; Xiao W; Hu J; Guan W; Wu L; Huang J; Huang Q; Xu H; Ye Z
    Clin Cancer Res; 2017 Jul; 23(13):3428-3441. PubMed ID: 27879367
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disturbances of alternative splicing in cancer].
    Wiszomirska H; Piekiełko-Witkowska A; Nauman A
    Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative splicing acts as an independent prognosticator in ovarian carcinoma.
    Ouyang Y; Xia K; Yang X; Zhang S; Wang L; Ren S; Zhou H; Liu Y; Tang F
    Sci Rep; 2021 May; 11(1):10413. PubMed ID: 34001978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
    Urbanski LM; Leclair N; Anczuków O
    Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AS-CMC: a pan-cancer database of alternative splicing for molecular classification of cancer.
    Park J; Lee JO; Lee M; Chung YJ
    Sci Rep; 2022 Dec; 12(1):21074. PubMed ID: 36473963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis.
    Chen F; Wang Q; Yu X; Yang N; Wang Y; Zeng Y; Zheng Z; Zhou F; Zhou Y
    Cell Death Dis; 2021 Apr; 12(4):370. PubMed ID: 33824311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.
    Stickeler E; Kittrell F; Medina D; Berget SM
    Oncogene; 1999 Jun; 18(24):3574-82. PubMed ID: 10380879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
    Zhao YJ; Wu LY; Pang JS; Liao W; Chen YJ; He Y; Yang H
    Bioengineered; 2021 Dec; 12(1):3978-3992. PubMed ID: 34288818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift.
    Luz FA; Brígido PC; Moraes AS; Silva MJ
    Oncology; 2017; 92(1):3-13. PubMed ID: 27794578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
    Wang Y; Wang Y; Li K; Du Y; Cui K; Yu P; Zhang T; Liu H; Ma W
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33000861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.